Pyridostigmine Bromide

Product NDC
64980-220
11-digit product format
649800220
Labeler code
64980
Product ID
64980-220_34812796-3684-4619-a70c-fc93e22d123a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Pyridostigmine Bromide
Dosage form
TABLET
Route
ORAL
Labeler
Rising Pharma Holdings, Inc.
Application
ANDA205464
Marketing category
ANDA
Marketing start
2017-08-15
Substance
PYRIDOSTIGMINE BROMIDE
Active strength
180 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A205464-001PYRIDOSTIGMINE BROMIDEPYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A205464-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-1531067a03dcf5…
2025-08-23 18:47 UTC2025-08A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-156a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-1503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-152680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-155bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-1579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-151e350fbaab3a…
2024-05-31 18:47 UTC2024-05A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-158072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-155c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-155d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-154b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-1574a2ff9319b5…
2022-03-09 01:35 UTC2022-03A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-1587673890dc5c…
2021-03-12 10:30 UTC2021-03A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-155aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-158869cabd3fbd…
2020-11-12 02:37 UTC2020-11A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15c0c555d07b60…
2019-12-14 00:12 UTC2019-12A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-153f01610625f2…
2019-09-15 20:21 UTC2019-09A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15b00525d2431f…
2019-07-19 19:46 UTC2019-07A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-156a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-151c564ffb4f44…
2023-12-20 04:57 UTC2023-12A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-159b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-153f0d92c62455…
2023-05-13 08:27 UTC2023-05A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15053a50430f4f…
2023-01-26 05:58 UTC2023-01A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-153bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-153a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A205464-001PYRIDOSTIGMINE BROMIDE180MGTABLET, EXTENDED RELEASE / ORALAB2017-08-15cb3db0bc1861…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A205464-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A205464-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A205464-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A205464-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A205464-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A205464-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A205464-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A205464-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A205464-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A205464-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A205464-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A205464-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A205464-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A205464-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A205464-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A205464-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A205464-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A205464-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A205464-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A205464-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A205464-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A205464-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A205464-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A205464-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A205464-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A205464-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A205464-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A205464-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A205464-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A205464-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A205464-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A205464-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A205464-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A205464-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A205464-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A205464-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A205464-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A205464-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A205464-001AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A205464-001AB1cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Pyridostigmine Bromide
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PYRIDOSTIGMINE BROMIDE180 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
KVI301NA53Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
903847Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
f7a75639-a23a-4847-a962-c091c61947f0Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cd6f4a37-8abf-2ed8-817f-5becdfa53ca5Product name920230112
dd640b44-88ec-4cbe-02c0-23127b95f5d3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64980-220-03Pyridostigmine Bromide30 in 1 BOTTLETABLET304

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
64980-220-03EA - Each64980-22048c7031f-43e6-4101-9ad9-621975ac0a5212018-12-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64980-220PYRIDOSTIGMINE BROMIDE TABLET [RISING PHARMACEUTICALS, INC.]3Current NDC, Legacy NDC, 1 package rows20221108_f7a75639-a23a-4847-a962-c091c61947f0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pyridostigmine BromidePYRIDOSTIGMINE BROMIDERising Pharma Holdings, Inc.f7a75639-a23a-4847-a962-c091c61947f02025-06-11Warnings, Adverse reactionsExact identifier
application applno (ANDA): 205464
application number: ANDA205464
ndc (product): 64980-220

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
903847pyRIDostigmine bromide 180 MG Extended Release Oral TabletPSNf7a75639-a23a-4847-a962-c091c61947f04
903847pyridostigmine bromide 180 MG Extended Release Oral TabletSCDf7a75639-a23a-4847-a962-c091c61947f04

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
64980-220-036498002200330 TABLET in 1 BOTTLE (64980-220-03) 30 tablet2017-08-150000-00-00NoNoCurrent